Agios Pharmaceuticals, Inc. Cash Flow Statement

Cash Flow Statement Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -34.37M-13.39M-35.56M-53.50M-117.73M-198.47M-314.67M-346.03M-110.06M1.94M1961.22M-231.80M-352.09M673.73M
Depreciation and Depletion 0.80M1.18M1.44M1.37M3.34M5.71M6.40M7.20M8.00M9.40M8.80M8.40M6.60M5.70M
Share-based Compensation 0.37M0.74M3.03M11.51M31.96M42.09M47.81M73.36M58.05M61.60M53.51M49.30M44.77M42.85M
Deferred Taxes -10.66M6.71M3.84M
Cash from Discontinued Operations -134.47M-46.81M-93.23M
Gains from Sales and Divestitures 0.18M0.18M0.14M0.01M0.01M0.01M
Gains from Investment Securities 0.10M3.15M3.85M3.81M4.62M5.22M-0.02M42.32M0.34M0.58M0.33M-0.55M0.04M
Non-cash Items 15.40M2.16M360.94M153.57M63.56M
Cash from Operations -15.22M-49.55M-56.40M-59.35M-76.95M38.56M-285.23M-304.42M-370.62M-290.76M-407.32M-309.48M-296.06M-389.84M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.39M-0.29M-0.28M-0.54M-0.54M-0.77M0.01M3.84M8.53M8.98M9.54M9.99M10.72M14.49M
Amortization of Deferred Charges 8.53M
Depreciation & Amortization (CF) 0.80M1.18M1.44M1.37M3.34M5.71M6.43M7.17M8.09M9.79M9.24M8.56M6.62M5.65M
Change in Working Capital
Change in Receivables 2.33M1.04M-0.28M-2.93M2.21M0.60M1.30M
Change in Inventory 0.87M6.46M8.49M10.58M8.54M
Change in Account Payables 0.81M-0.32M0.03M7.58M4.21M3.50M5.33M-5.49M4.16M3.33M1.86M3.44M-8.73M6.60M
Change in Accured Expenses 0.53M0.16M4.88M5.23M1.63M16.85M1.52M8.62M-0.82M6.76M0.07M3.00M12.82M3.69M
Change in Taxes 17.87M-12.99M-3.30M-5.30M3.84M0.87M
Investing Activities
Capital Expenditures 1.91M1.48M1.29M2.22M20.16M9.91M4.63M6.99M12.03M14.11M5.74M4.88M1.00M1.69M
Sales of Property, Plant and Equipment 0.96M1.32M0.04M
Divestments -0.14M-0.80M1802.94M200.00M
Change in Acquisitions & Divestments 85.48M113.04M60.13M505.53M501.65M396.63M635.42M666.48M592.18M647.68M829.80M1146.17M674.68M818.38M
Cash from Investing Activities -22.36M23.04M-87.22M-333.34M128.31M-119.35M-57.91M-273.82M91.58M76.55M1248.78M243.26M239.57M363.44M
Financing Activities
Other financing activities 2.39M0.72M0.21M0.23M-0.64M0.39M250.54M
Change in Capital Stock
Shares Issued 0.06M0.14M12.75M333.58M6.58M162.15M270.25M516.21M277.20M11.32M37.30M2.68M5.43M14.44M
Shares Repurchased 0.06M0.06M0.06M0.01M0.01M802.49M
Preferred Shares Issued 77.30M
Misc.
Cash from Financing Activities 77.36M0.14M123.88M335.16M6.37M169.78M285.11M546.02M289.61M261.52M-765.77M2.35M5.43M14.44M
Change in Cash 39.78M-26.36M-19.74M-57.53M57.73M88.99M-58.03M-32.22M10.43M46.51M75.69M-63.87M-51.05M-11.96M
Free Cash Flow -17.12M-51.02M-57.69M-61.57M-97.11M28.65M-289.86M-311.41M-382.65M-304.87M-413.06M-314.36M-297.06M-391.53M
Net Cash Flow 39.78M-26.36M-19.74M-57.53M57.73M88.99M-58.03M-32.22M10.57M47.31M75.69M-63.87M-51.05M-11.96M